PharmaCCX, Inc. — Form D
PharmaCCX, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-18. The offering totals $5.4M, of which $5.4M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-07-18
- Form: D
- Accession: 0001759780-23-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.4M
- Amount sold: $5.4M
- Remaining: $50K
- Investors: 24
- Date of first sale: 2023-06-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-487208
Issuer
- Name: PharmaCCX, Inc.
- CIK: 0001759780
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 867 Boylston Street, Boston, MA, 02116
- Phone: 508-658-9080
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Julia Shankar Bernstein | Director | Boston, MA |
| Rob Shankar Kniaz | Director | Boston, MA |
| Nathan Sigworth | Director | Boston, MA |
| Barath Shankar Subramanian | Director | Boston, MA |
| Peter Rice | Executive Officer | Boston, MA |
| Nathan Sigworth | Executive Officer | Boston, MA |
| Armen Shankar Solakhyan | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More